Taking a look at Thermo Fisher Scientific as data shows that healthcare is one of the sectors that tends to perform well in the following 12 months after the first Fed rate cut. Of course, past performance is not a guarantee of the future. Yesterday, the stock’s shares closed the trading session at around $620.38 a share and are up around 17% year-to-date. Looking at the monthly chart, it is clear that the all-time high of $672.40 will act as a tough resistance point here for TFS. A break above will be a bullish indication, but even after a break higher, the stock may want to re-test this level as support before potentially continuing higher. Securing $700 could then pave the way for a rally toward $800. This creates an opportunity for a gain of 29% from current levels, but for those who are more risk averse and would prefer more certainty by waiting for a break above $700 first, this would then offer a possible gain of over 14%. However, this is simply speculation but the risk to reward from a momentum base perspective is more attractive now than if the stock was to reach $700 a share. Primary support to keep an eye on is the price level of $522.83, only a break below here would present a real threat to future gains. The technical indicators signal that bullish momentum has returned as the MACD has crossed above its signal line and is rising. The RSI is also within bullish territory as it reads 60.